Total Payments
$96,470
2024 Payments
$3,385
Companies
56
Transactions
1,239
Medicare Patients
9,057
Medicare Billing
$1.1M
Payment Breakdown by Category
Research$47,024 (48.7%)
Food & Beverage$21,601 (22.4%)
Other$18,415 (19.1%)
Consulting$4,732 (4.9%)
Travel$4,333 (4.5%)
Education$364.28 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $47,024 | 16 | 48.7% |
| Food and Beverage | $21,601 | 1,162 | 22.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,400 | 15 | 19.1% |
| Consulting Fee | $4,732 | 2 | 4.9% |
| Travel and Lodging | $4,333 | 26 | 4.5% |
| Education | $364.28 | 17 | 0.4% |
| Entertainment | $15.39 | 1 | 0.0% |
Payments by Type
General
$49,446
1,223 transactions
Research
$47,024
16 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $47,755 | 19 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $22,544 | 129 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $6,306 | 72 | $0 (2024) |
| Novo Nordisk AS | $3,152 | 14 | $0 (2019) |
| Amgen Inc. | $2,312 | 97 | $0 (2024) |
| Novo Nordisk Inc | $2,298 | 204 | $0 (2024) |
| Lilly USA, LLC | $1,805 | 128 | $0 (2024) |
| ABBVIE INC. | $1,087 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $952.29 | 46 | $0 (2024) |
| PFIZER INC. | $944.64 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,385 | 149 | Amgen Inc. ($503.58) |
| 2023 | $3,553 | 156 | Amgen Inc. ($487.12) |
| 2022 | $3,288 | 128 | Eli Lilly and Company ($981.00) |
| 2021 | $1,482 | 99 | Amgen Inc. ($255.32) |
| 2020 | $9,192 | 78 | Eli Lilly and Company ($6,802) |
| 2019 | $22,121 | 182 | Eli Lilly and Company ($15,722) |
| 2018 | $36,868 | 210 | Eli Lilly and Company ($23,952) |
| 2017 | $16,582 | 237 | AstraZeneca Pharmaceuticals LP ($5,942) |
All Payment Transactions
1,239 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $109.68 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: VACCINES | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $33,853 | 4 |
| A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK | Eli Lilly and Company | $5,687 | 4 |
| A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | Eli Lilly and Company | $4,292 | 3 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL COMPARING THE EFFICACY AND SAFETY OF THREE TIRZEPATIDE DOSES VERSUS PLACEBO IN PATIENTS WITH TYPE 2 DIABETES, INADEQUATELY CONTROLLED WITH DIET AND EXERCISE ALONE | Eli Lilly and Company | $1,914 | 2 |
| A PHASE 2 STUDY OF ONCE-DAILY LY3502970 COMPARED WITH PLACEBO AND ONCE-WEEKLY DULAGLUTIDE IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $534.00 | 1 |
| EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY VERSUS PLACEBO FOR MAINTENANCE OF WEIGHT LOSS IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-4) | Eli Lilly and Company | $447.00 | 1 |
| EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY VERSUS PLACEBO FOR MAINTENANCE OF WEIGHT LOSS IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (SURMOUNT-4) | Eli Lilly and Company | $297.96 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,077 | 4,087 | $338,225 | $249,519 |
| 2022 | 20 | 2,148 | 4,225 | $330,888 | $249,806 |
| 2021 | 20 | 2,354 | 6,464 | $389,182 | $292,134 |
| 2020 | 23 | 2,478 | 6,950 | $381,830 | $277,491 |
Total Patients
9,057
Total Services
21,726
Medicare Billing
$1.1M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 351 | 1,564 | $202,714 | $134,590 | 66.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 303 | 303 | $39,676 | $38,872 | 98.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 289 | 289 | $25,216 | $22,850 | 90.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 230 | 232 | $16,105 | $15,577 | 96.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 127 | 132 | $11,365 | $7,886 | 69.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 30 | $8,401 | $6,586 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 138 | $12,793 | $6,431 | 50.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 229 | 231 | $3,296 | $3,162 | 96.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 22 | 106 | $3,729 | $2,547 | 68.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $3,377 | $2,538 | 75.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 103 | 103 | $1,903 | $1,822 | 95.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 30 | $2,056 | $1,386 | 67.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 29 | 39 | $1,879 | $1,270 | 67.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 26 | 28 | $1,870 | $1,259 | 67.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 79 | $1,148 | $838.57 | 73.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 78 | 203 | $680.00 | $637.83 | 93.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 55 | $840.57 | $450.17 | 53.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 16 | 88 | $608.31 | $429.22 | 70.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 35 | 397 | $460.40 | $305.87 | 66.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 24 | $109.57 | $81.84 | 74.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 376 | 1,593 | $206,986 | $139,878 | 67.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 290 | 290 | $38,670 | $37,885 | 98.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 298 | 299 | $25,523 | $24,176 | 94.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 227 | 228 | $15,942 | $15,555 | 97.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 167 | $15,454 | $9,064 | 58.7% |
About Dr. Eric Klein, MD
Dr. Eric Klein, MD is a Internal Medicine healthcare provider based in Olympia, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083612568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Klein, MD has received a total of $96,470 in payments from pharmaceutical and medical device companies, with $3,385 received in 2024. These payments were reported across 1,239 transactions from 56 companies. The most common payment nature is "" ($47,024).
As a Medicare-enrolled provider, Klein has provided services to 9,057 Medicare beneficiaries, totaling 21,726 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Olympia, WA
- Active Since 07/08/2005
- Last Updated 07/30/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083612568
Products in Payments
- TRULICITY (Drug) $35,353
- FARXIGA (Drug) $21,905
- SOLIQUA (Drug) $5,290
- Ozempic (Drug) $1,228
- FIASP (Drug) $1,224
- Otezla (Drug) $882.90
- JARDIANCE (Drug) $851.64
- ENTRESTO (Drug) $729.76
- Aimovig (Biological) $699.00
- Saxenda (Drug) $674.92
- XARELTO (Drug) $643.98
- QULIPTA (Drug) $498.69
- UBRELVY (Drug) $472.52
- ELIQUIS (Drug) $426.07
- Korlym (Drug) $398.36
- EVENITY (Biological) $383.99
- Wegovy (Drug) $346.66
- Victoza (Drug) $342.81
- BREZTRI (Drug) $338.08
- MOUNJARO (Drug) $301.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Olympia
Shawna Purcell
Internal Medicine — Payments: $278,367
Internal Medicine $278,367
Sabrina Benjamin, Md, MD
Internal Medicine — Payments: $60,477
Internal Medicine $60,477
Dr. Rebecca March, Do, DO
Internal Medicine — Payments: $19,071
Internal Medicine $19,071
Dr. Curtis Reinke, Md, MD
Internal Medicine — Payments: $16,927
Internal Medicine $16,927
Daryl Sudasena
Internal Medicine — Payments: $10,873
Internal Medicine $10,873
Haroon Yousaf, Md, MD
Internal Medicine — Payments: $10,507
Internal Medicine $10,507